-
New Data From Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 -15
AmericanPharmaceuticalReview
November 23, 2021
Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
-
Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to four nations
ExpressPharma
November 23, 2021
The Union government has allowed the Serum Institute of India (SII) to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine programme to Nepal, Tajikistan and Mozambique, official sources said.
-
Pfizer Says Its COVID Vaccine Provides Full Protection to Adolescents
Drugs
November 23, 2021
Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants.
-
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
prnasia
November 22, 2021
At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological Products Co., Ltd. will depart from...
-
Cell-free protein synthesis could enable decentralised conjugate vaccine production
EuropeanPharmaceuticalReview
November 22, 2021
According to the developers, iVAX – a modular technology for in vitro conjugate vaccine expression – is portable and could overcome the challenges of ensuring cold-chain supply of conjugate vaccine products...
-
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose
PharmaTimes.
November 19, 2021
Following a review of evidence by the Joint Committee on Vaccination and Immunisation (JCVI), the UK Health Security Agency (UKHSA) has published new clinical guidance on vaccinations for 12 to 17 year olds.
-
Less Than One Year After Approval, Two Billion Doses of AstraZeneca’s COVID-19 Vaccine Have Been Supplied Globally
AmericanPharmaceuticalReview
November 19, 2021
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months.
-
Europe to donate 70 million doses of Moderna’s COVID-19 vaccine
EuropeanPharmaceuticalReview
November 19, 2021
Moderna has announced an agreement that enables the European Union (EU) and European Economic Area (EEA) countries to donate doses of Spikevax, previously COVID-19 Vaccine Moderna...
-
Philippine FDA grants EUA to Novavax’s Covid-19 vaccine
Pharmaceutical-Technology
November 19, 2021
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Novavax’s Covid-19 vaccine, NVX-CoV2373, for active immunisation of people aged 18 years and above.
-
India has robust manufacturing capability with sufficient skilled manpower to foster innovation
ExpressPharma
November 19, 2021
Give us an overview of the major advancements, shifts and trends in healthcare and lifesciences due to the COVID-19 pandemic. How will these spur investments in the research and manufacturing of biopharmaceuticals in India?